The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available that are not considered orphan products.

• Paclitaxel protein-bound particles (Brand name: Abraxane) - Manufactured by Abraxis BioScience, LLC
  FDA-approved indication: Treatment of metastatic adenocarcinoma of the pancreas as first-line treatment, in combination with gemcitabine.
  National Library of Medicine Drug Information Portal Medline Plus Health Information

  Learn more about Pancreatic cancer

• Liposomal irinotecan (Brand name: Onivyde) - Manufactured by Merrimack Pharmaceuticals, Inc.
  FDA-approved indication: For use in combination with 5-fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas that has progressed following gemcitabine-based therapy.
  National Library of Medicine Drug Information Portal Medline Plus Health Information

  Learn more about Pancreatic cancer